TEL AVIV, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative ...
TEL AVIV, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative ...
Nasus Pharma Ltd (NYSE:NSRX) has filed to raise $11 million in an IPO of its ordinary shares, according to SEC F-1 registration information. The company is developing an intranasal powder spray for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback